Category Archives: Clinical Trials

FDA Guidance on Clinical Trials During COVID-19 Pandemic

Much attention has been paid to the impact of the COVID-19 pandemic on the supply chain for medicines we rely on, but there has been less focus on the impact of medicines yet to come. The advancements in cancer care … Continue reading

Posted in Clinical Trials, FDA Policy | Tagged | Comments Off on FDA Guidance on Clinical Trials During COVID-19 Pandemic

Taking a Peek at Transparency – An FDA Pilot Program

Yesterday, Commissioner Scott Gottlieb announced a new effort on the part of the agency aimed at increasing transparency around clinical trials, a goal long sought by many patient advocates, particularly outside the U.S.  Specifically, FDA is introducing a pilot program … Continue reading

Posted in Clinical Trials, FDA Policy | 2 Comments

FDA and Patient Involvement

“I am a cancer survivor, I was treated for cancer during my last tour at FDA, so I k now the importance of what American medicine does — and what the FDA does — for every one of us.” Scott … Continue reading

Posted in Clinical Trials, FDA Image, FDA Policy | Comments Off on FDA and Patient Involvement

NIH Clinical Trials and You

For a long time, I have thought that clinical trial information was too clinical to be of much use for patients who might be considering entering one.  The information available was either in the form of searchable data bases, text … Continue reading

Posted in Clinical Trials | 1 Comment

Clinical Trials and Search

You are sitting in the doctor’s office on that crinkly paper that pops every time you move. Your physician is leaning against a table and has just uttered some words that were a diagnosis.  It is a serious diagnosis.  For … Continue reading

Posted in Clinical Trials | 2 Comments